Biogen Aktie
WKN: 789617 / ISIN: US09062X1037
13.02.2024 13:14:36
|
Biogen Inc. Q4 Profit Decreases, misses estimates
(RTTNews) - Biogen Inc. (BIIB) reported earnings for fourth quarter that decreased from last year and missed the Street estimates.
The company's earnings came in at $249.7 million, or $1.71 per share. This compares with $550.4 million, or $3.79 per share, in last year's fourth quarter.
Excluding items, Biogen Inc. reported adjusted earnings of $430.3 million or $2.95 per share for the period.
Analysts on average had expected the company to earn $3.18 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter fell 5.9% to $2.39 billion from $2.54 billion last year.
Biogen Inc. earnings at a glance (GAAP) :
-Earnings (Q4): $249.7 Mln. vs. $550.4 Mln. last year. -EPS (Q4): $1.71 vs. $3.79 last year. -Analyst Estimates: $3.18 -Revenue (Q4): $2.39 Bln vs. $2.54 Bln last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Biogen Incmehr Nachrichten
Analysen zu Biogen Incmehr Analysen
Aktien in diesem Artikel
Biogen Inc | 117,45 | -0,47% |
|